The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism
Abstract
Eight double-blind placebo-controlled clinical trials in five countries have demonstrated the safety and efficacy of naltrexone as an adjunct in alcoholism treatment. The efficacy depends, however, on how naltrexone is used. Three of the trials tested naltrexone in two ways: (1) with supportive therapy, i.e. support of complete abstinence; (2) with therapy tacitly accepting that relapses may occur and teaching how to cope with them. Although all found benefits from naltrexone with the coping therapy, none of them found any significant benefit of naltrexone over placebo when combined with support for abstinence. These results are consistent with our pre-clinical studies in which naltrexone, naloxone, and nalmefene were effective when paired with drinking but ineffective when given during abstinence. This supported the hypothesis that the primary mechanism involved is extinction (as had been concluded earlier for the effects of naltrexone in opiate addiction treatment), because extinction only weakens responses that are made while reinforcement is blocked. On this basis, it was proposed that: (1) naltrexone should be administered to patients who were still currently drinking; (2) the instructions should be to take naltrexone only when drinking was anticipated; (3) this treatment should continue indefinitely. Subsequently, clinical trials have found that naltrexone used in this manner is safe and effective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Cited by
Opioid antagonists for alcohol dependence
Srisurapanont, M., & Jarusuraisin, N. (2002) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867 · Cited by 764
Carmen, B., Angeles, M., Ana, M., & María, A. J. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00763.x · Cited by 504
Harm reduction approaches to alcohol use
Marlatt, G. A., & Witkiewitz, K. (2002) · Addictive Behaviors · doi:10.1016/s0306-4603(02)00294-0 · Cited by 491
Maisel, N. C., Blodgett, J. C., Wilbourne, P. L., Humphreys, K., & Finney, J. W. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04054.x · Cited by 470
Gual, A., He, Y., Torup, L., van den Brink, W., & Mann, K. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.02.006 · Cited by 407
Opioid peptides and the control of human ingestive behaviour
Yeomans, M. R., & Gray, R. W. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(02)00041-6 · Cited by 317
Rösner, S., Leucht, S., Lehert, P., & Soyka, M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107078308 · Cited by 300
FRIEDLANDER, A. H., MARDER, S. R., PISEGNA, J. R., & YAGIELA, J. A. (2003) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2003.0260 · Cited by 269
Breese, G. R., Sinha, R., & Heilig, M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.007 · Cited by 261
Circuitry of self-control and its role in reducing addiction
Tang, Y.-Y., Posner, M. I., Rothbart, M. K., & Volkow, N. D. (2015) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2015.06.007 · Cited by 236
Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders
Petrakis, I. L., Poling, J., Levinson, C., Nich, C., Carroll, K., & Rounsaville, B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.016 · Cited by 177
Conceptual framework for the etiology of alcoholism: a “kindling”/stress hypothesis
Breese, G. R., Overstreet, D. H., & Knapp, D. J. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2016-2 · Cited by 167
Zangen, A., Ikemoto, S., Zadina, J. E., & Wise, R. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07225.2002 · Cited by 138
Tanda, G., Munzar, P., Goldberg, S. R., & Justinova, Z. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1693-6 · Cited by 111
Reduced Drinking in Alcohol Dependence Treatment, What Is the Evidence?
Mann, K., Aubin, H.-J., & Witkiewitz, K. (2017) · European Addiction Research · doi:10.1159/000481348 · Cited by 93
CLINICAL STUDY: Does naltrexone affect craving in abstinent opioid‐dependent patients?
Dijkstra, B. A. G., De Jong, C. A. J., Bluschke, S. M., Krabbe, P. F. M., & Van Der Staak, C. P. F. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00067.x · Cited by 24
Reuter, A., Beko, B., Memani, B., Furin, J., Daniels, J., Rodriguez, E., Reuter, H., Weich, L., Isaakidis, P., von der Heyden, E., et al. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7020021 · Cited by 9
(2014) · Työväentutkimus Vuosikirja · Cited by 1
Metadata
- Authors
- Sinclair, J. D.
- Venue
- Alcohol and Alcoholism
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-01-01
- Volume
- 36
- Issue
- 1
- Pages
- 2-10
- ISSN
- 0735-0414 (ISSN-L)
- 1464-3502
- OpenAlex
- W2107677036
- Cited by
- 174
- References
- 1
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.